<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Drug</title>
<description>International Business News - Drug</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>XenoPort says pain drug meets main goal of trial</title>
  <description>Biopharmaceutical company XenoPort Inc and its partner GlaxoSmithKline Plc said their neuropathic pain drug met the main goal of reducing the intensity of pain in a mid-stage trial.</description>
    <link>http://www.ibtimes.com/articles/20090917/xenoport-says-pain-drug-meets-main-goal-trial.htm</link> 
  <pubDate>Thu, 17 Sep 2009 11:49:56 EDT</pubDate>
  </item>


  <item>
  <title>Ariad says independent experts positive on cancer drug</title>
  <description>Ariad Pharmaceuticals Inc said an independent committee of experts recommended that a late-stage trial of the company's experimental cancer treatment may continue.</description>
    <link>http://www.ibtimes.com/articles/20090914/ariad-says-independent-experts-positive-on-cancer-drug.htm</link> 
  <pubDate>Mon, 14 Sep 2009 09:13:53 EDT</pubDate>
  </item>


  <item>
  <title>Alexza migraine drug fails to meet goal in study</title>
  <description>Alexza Pharmaceuticals Inc said preliminary results from a mid-stage trial of its migraine drug showed it did not meet the primary goal of headache pain-relief at two hours post-dose.</description>
    <link>http://www.ibtimes.com/articles/20090914/alexza-migraine-drug-fails-meet-goal-study.htm</link> 
  <pubDate>Mon, 14 Sep 2009 08:47:16 EDT</pubDate>
  </item>


  <item>
  <title>Vivus says obesity drug effective; shares soar</title>
  <description>An experimental obesity drug made by Vivus Inc showed dramatic results in two late- stage clinical trials, potentially offering patients a much- needed weight-loss aid and sending the company's shares soaring more than 70 percent.</description>
    <link>http://www.ibtimes.com/articles/20090909/vivus-says-obesity-drug-effective-shares-soar.htm</link> 
  <pubDate>Wed, 09 Sep 2009 16:36:28 EDT</pubDate>
  </item>


  <item>
  <title>Opexa shares soar on multiple sclerosis drug data</title>
  <description>Opexa Therapeutics Inc  said on Tuesday further analysis of clinical data shows that more than 83 percent of patients taking its experimental multiple sclerosis drug remained relapse-free after a year, more than doubling the value of the company's shares.</description>
    <link>http://www.ibtimes.com/articles/20090908/updateopexa-shares-soar-on-multiple-sclerosis-drug-data.htm</link> 
  <pubDate>Tue, 08 Sep 2009 10:52:49 EDT</pubDate>
  </item>


  <item>
  <title>Acadia psychosis drug misses main goal; shrs sink</title>
  <description>Acadia Pharmaceuticals Inc said on Tuesday its experimental drug for psychosis related to Parkinson's disease failed to meet its primary goal in a late-stage trial, sending its shares down 70 percent.
</description>
    <link>http://www.ibtimes.com/articles/20090901/acadia-psychosis-drug-misses-main-goal-shrs-sink.htm</link> 
  <pubDate>Tue, 01 Sep 2009 09:35:57 EDT</pubDate>
  </item>


  <item>
  <title>UPDATE 2-US FDA staff question Allos lymphoma drug data</title>
  <description>WASHINGTON - U.S. drug reviewers questioned findings from biotech company Allos Therapeutics Inc (ALTH.O) on the effectiveness of its proposed drug for an aggressive type of lymphoma, documents released on Friday showed.</description>
    <link>http://www.ibtimes.com/articles/20090828/update-us-fda-staff-question-allos-lymphoma-drug-data.htm</link> 
  <pubDate>Fri, 28 Aug 2009 13:10:26 EDT</pubDate>
  </item>


  <item>
  <title>Facet, Trubion in drug development deal, Trubion stock soars</title>
  <description>Facet Biotech Corp (FACT.O) and Trubion Pharmaceuticals Inc (TRBN.O) agreed to jointly develop and market Trubion's experimental drug for a type of blood cancer, the companies said, sending Trubion shares up 76 percent.</description>
    <link>http://www.ibtimes.com/articles/20090828/facet-trubion-drug-development-deal-trubion-stock-soars.htm</link> 
  <pubDate>Fri, 28 Aug 2009 10:22:55 EDT</pubDate>
  </item>


  <item>
  <title>UPDATE 1-US FDA staff question Genzyme leukemia drug study</title>
  <description>WASHINGTON - U.S. drug reviewers questioned a Genzyme Corp (GENZ.O) study meant to back wider use of the company's Clolar leukemia drug, according to documents released on Friday ahead of an advisory panel review.</description>
    <link>http://www.ibtimes.com/articles/20090828/us-fda-staff-question-genzyme-leukemia-drug-study.htm</link> 
  <pubDate>Fri, 28 Aug 2009 08:28:22 EDT</pubDate>
  </item>


  <item>
  <title>Industry blames price gap for UK drug shortages</title>
  <description>A widening price gap, fuelled by a weak pound, is behind the current shortage of some medicines in Britain as more drugs are exported by middlemen for profit, the pharmaceutical industry said on Tuesday.</description>
    <link>http://www.ibtimes.com/articles/20090825/industry-blames-price-gap-uk-drug-shortages.htm</link> 
  <pubDate>Tue, 25 Aug 2009 08:20:42 EDT</pubDate>
  </item>


  <item>
  <title>Drug war hits Mexican economy in crisis</title>
  <description>Mexico&amp;#039;s economy, already in recession, is being dragged even lower by a brutal drug war that is frightening off some investors and hurting the Mexican currency.</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/211629-.jpg</url>
  <link>http://www.ibtimes.com/articles/20090403/drug-war-hits-mexican-economy-crisis.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20090403/drug-war-hits-mexican-economy-crisis.htm</link> 
  <pubDate>Fri, 03 Apr 2009 20:45:27 EDT</pubDate>
  </item>


</channel>
</rss>